RedHill Biopharma Ltd.
RDHL
$2.26
$0.199.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -67.75% | 0.00% | 88.60% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -51.91% | 0.00% | 3.21% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 130.25% | 0.00% | -134.02% | 0.00% |
| Change in Net Operating Assets | 0.00% | -91.61% | 0.00% | 126.08% | 0.00% |
| Cash from Operations | 0.00% | 48.52% | 0.00% | 65.72% | 0.00% |
| Capital Expenditure | 0.00% | -700.00% | 0.00% | 75.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Investing | 0.00% | -700.00% | 0.00% | -109.09% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 46.38% | 0.00% | 29.35% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | 0.00% | -6.76% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 1,349.02% | 0.00% | -99.39% | 0.00% |
| Cash from Financing | 0.00% | -93.46% | 0.00% | -52.48% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 350.00% | 0.00% | 68.42% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -255.74% | 0.00% | 219.69% | 0.00% |